Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duvuru Geetha

Showing results (101-110 of 146) with videos related to

Pageof 15
Sort By:
Clinical Rheumatology|May 1, 2019
Uncommon presentations in ANCA vasculitis: clinical characteristics and outcomesVeena S Katikineni, Sam Kant, Eric J Gapud, et al.
Kidney International Reports|September 11, 2018
Comparisons of Guidelines and Recommendations on Managing Antineutrophil Cytoplasmic Antibody-Associated VasculitisDuvuru Geetha, Qiuyu Jin, Jennifer Scott, et al.
RMD Open|October 6, 2025
Efficacy and safety of avacopan for treatment of patients with ANCA-associated vasculitis receiving cyclophosphamideDuvuru Geetha, Thomas Neumann, Alexandre Karras, et al.
Journal of Nephrology|September 9, 2022
Urinary cell mRNA profiling distinguishes disease activity in antineutrophil cytoplasmic antibody-associated glomerulonephritisLillian Xu, Sam Kant, Faten Aqeel, et al.
Lupus|January 2, 2024
COVID vaccine-induced lupus nephritis: Case report and review of the literatureAntonio Salas, Ayotola Fatola, Rebecca Krimins, et al.
Rheumatology (Oxford, England)|January 9, 2025
Differences in phenotypes, treatments, and outcomes of ANCA-associated vasculitis across Europe, Japan and the USA in 2020Satoshi Omura, Takashi Kida, Andreas Kronbichler, et al.
Annals of the Rheumatic Diseases|August 3, 2021
Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli <i>et al</i>Caoilfhionn Marie Connolly, Darya Koenig, Srekar N Ravi, et al.
Kidney International Reports|June 2, 2018
Patient Outcomes in Renal-Limited Antineutrophil Cytoplasmic Antibody Vasculitis With Inactive HistologyTessa K Novick, Min Chen, Jennifer Scott, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 21, 2023
KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular DiseasesLaurence H Beck, Isabelle Ayoub, Dawn Caster, et al.
Kidney International Reports|December 20, 2021
SARS-CoV-2 Vaccine Response in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated VasculitisLauren Floyd, Mohamed E Elsayed, Tobias Seibt, et al.
Pageof 15

Showing results (101-110 of 146) with videos related to

Sort By:
Pageof 15
Clinical Rheumatology|May 1, 2019
Uncommon presentations in ANCA vasculitis: clinical characteristics and outcomesVeena S Katikineni, Sam Kant, Eric J Gapud, et al.
Kidney International Reports|September 11, 2018
Comparisons of Guidelines and Recommendations on Managing Antineutrophil Cytoplasmic Antibody-Associated VasculitisDuvuru Geetha, Qiuyu Jin, Jennifer Scott, et al.
RMD Open|October 6, 2025
Efficacy and safety of avacopan for treatment of patients with ANCA-associated vasculitis receiving cyclophosphamideDuvuru Geetha, Thomas Neumann, Alexandre Karras, et al.
Journal of Nephrology|September 9, 2022
Urinary cell mRNA profiling distinguishes disease activity in antineutrophil cytoplasmic antibody-associated glomerulonephritisLillian Xu, Sam Kant, Faten Aqeel, et al.
Lupus|January 2, 2024
COVID vaccine-induced lupus nephritis: Case report and review of the literatureAntonio Salas, Ayotola Fatola, Rebecca Krimins, et al.
Rheumatology (Oxford, England)|January 9, 2025
Differences in phenotypes, treatments, and outcomes of ANCA-associated vasculitis across Europe, Japan and the USA in 2020Satoshi Omura, Takashi Kida, Andreas Kronbichler, et al.
Annals of the Rheumatic Diseases|August 3, 2021
Correspondence on "SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response" by Bonelli <i>et al</i>Caoilfhionn Marie Connolly, Darya Koenig, Srekar N Ravi, et al.
Kidney International Reports|June 2, 2018
Patient Outcomes in Renal-Limited Antineutrophil Cytoplasmic Antibody Vasculitis With Inactive HistologyTessa K Novick, Min Chen, Jennifer Scott, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 21, 2023
KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular DiseasesLaurence H Beck, Isabelle Ayoub, Dawn Caster, et al.
Kidney International Reports|December 20, 2021
SARS-CoV-2 Vaccine Response in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated VasculitisLauren Floyd, Mohamed E Elsayed, Tobias Seibt, et al.
Pageof 15